Ivim Health Recognized as Best GLP-1 Telehealth Platform
In an impressive feat for Ivim Health, the company has recently been awarded the title of
Best GLP-1 Telehealth Platform by
U.S. News & World Report for the year 2026-2027. This accolade reflects Ivim's commitment to providing outstanding telehealth services in the field of weight management, hormone health, and chronic disease treatment, particularly focusing on GLP-1 therapies.
This recognition follows the company’s recent ranking at
No. 38 on the
Inc. 5000 list of the fastest-growing private companies in America. It highlights not only Ivim's rapid growth but also its dedication to high-quality care as demonstrated by nearly
40,000 patient reviews on Trustpilot, yielding an impressive average rating of
4.9 stars.
A Closer Look at the Evaluation Process
The evaluation by
U.S. News & World Report involved analyzing
20 GLP-1 telehealth platforms, utilizing
14,161 data points and feedback from more than
1,200 active users. They were measured across six critical areas:
- - Clinical Support (25%)
- - Screening Rigor (20%)
- - Transparency (17%)
- - Insurance Assistance (15%)
- - Supplemental Care (13%)
- - Overall Customer Satisfaction (10%)
According to Dr. Jessica Duncan, the Chief Medical Officer at Ivim Health, emphasis was placed on clinical support and screening rigor. “Writing a prescription is the easy part. The real results come from continuous monitoring and adjustments,” she noted. This insight underscores Ivim's philosophy of treating patients with a comprehensive approach instead of a one-size-fits-all treatment plan.
Since earlier in the year, Ivim has also published two peer-reviewed studies in
Obesity Pillars, covering treatment protocols and results based on their extensive patient care efforts.
The Importance of Patient Care and Trust
As reported by
U.S. News, the demand for weight management solutions is at an all-time high. This makes it crucial for platforms to maintain high standards in clinical oversight and transparency. Gretel Schueller, managing editor of health at
U.S. News, added that this recognition reflects Ivim’s commitment to helping patients navigate quality GLP-1 care effectively.
Patients seeking telehealth solutions for GLP-1 treatment are encouraged to consult their primary care providers to ensure any platform aligns with their specific health needs. The findings can assist consumers in making informed decisions regarding their healthcare by utilizing these independent resources.
About Ivim Health
Based in Columbus, Ohio, Ivim Health is a national virtual healthcare provider focused on personalized weight management and treatment for cardiometabolic conditions, including obesity. With a strong team of nearly
100 licensed medical professionals spanning all
50 states, the company offers tailored care through telehealth. Their services include GLP-1 weight management, Women's Hormone Health, and Men's Hormone Health, designed around a model that integrates clinical treatments with ongoing patient support.
With a commitment to quality care, Ivim holds one of the highest ratings for telehealth weight loss platforms, further consolidating its status as a leader in the evolving landscape of online healthcare.
For further insights, visit the full ratings and methodology on U.S. News' website, or check out their comprehensive GLP-1 Consumer Guide for additional treatment options.